Unstable angina/ NSTEMI resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 47: Line 47:
{{familytree  | | | F01 | | F02 | | F03 | | F04 | | F01= LOW RISK | F02= HIGH RISK | F03= NEGATIVE | F04= POSITIVE}}
{{familytree  | | | F01 | | F02 | | F03 | | F04 | | F01= LOW RISK | F02= HIGH RISK | F03= NEGATIVE | F04= POSITIVE}}
{{familytree  | | | |!| | | |!| | | |!| | | |!| }}
{{familytree  | | | |!| | | |!| | | |!| | | |!| }}
{{familytree  | | | G01 | | |!| | | G02 | | |!| G01= | G02=}}
{{familytree  | | | G01 | | |!| | | G02 | | |!| G01= | G02= ❑ Continue Aspirin <br>
❑ Continue with clopidrogel or tucagelor for 12 months <br>
❑ Discontinue with GP inhibitors <br>
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)}}
{{familytree  | |,|-|^|-|.| |!| | | | | | | |!| }}
{{familytree  | |,|-|^|-|.| |!| | | | | | | |!| }}
{{familytree  | H01 | | H02 |!| | | | | | | |!| H01= | H02=}}
{{familytree  | H01 | | H02 |!| | | | | | | |!| H01= | H02=}}
Line 54: Line 57:
{{familytree  | | | | | | J01 | | | | | | | | | J01= }}
{{familytree  | | | | | | J01 | | | | | | | | | J01= }}
{{familytree  | | | | |,|-|^|-|.| | | | | | | | }}
{{familytree  | | | | |,|-|^|-|.| | | | | | | | }}
{{familytree  | | | | K01 | | K02 | | | | | K01= | K02=}}
{{familytree  | | | | K01 | | K02 | | | | | K01= ❑ Continue Aspirin <br>
❑ Continue with clopidrogel or tucagelor for 12 months <br>
❑ Discontinue with GP inhibitors <br>
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)| K02=}}
{{familytree  | | | | | | |,|-|^|-|.| | | | }}
{{familytree  | | | | | | |,|-|^|-|.| | | | }}
{{familytree  | | | | | | L01 | | L02 | | | L01= | L02=}}
{{familytree  | | | | | | L01 | | L02 | | | L01= | L02=}}

Revision as of 16:42, 27 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Definition

Causes

Life Threatening Causes

Common Causes

Management

Diagnosis

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Treatment

 
 
 
 
 
 
 
 
❑ Administer 300mg Aspirin immediately after hospital admission

❑ Administer oxygen in patients with saturation <90%
❑ Administer nitroglycerine sub-lingual ADD DOSES
❑ Administer morphine IV initial dose 2-4mg with increments of 2-8mg every 5 to 15 minutes
❑ Administer beta-blockers to all patients without contraindications
❑ Administer statins, atorvastatine 80mg

❑ Initiate anti thrombotic therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determine Risk of adverse coronary event (TIMI)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOW RISK
Initial conservative strategy
 
 
 
 
 
HIGH RISK
Initial invasive strategy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Administer 300mg of copidogrel
❑ Administer fondoparinaux or UFH in case of renal failure
 
 
 
 
 
❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban)

OR

❑ Administer Bivalirudin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform a Stress test
 
 
 
 
 
Angiography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOW RISK
 
HIGH RISK
 
NEGATIVE
 
POSITIVE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Continue Aspirin

❑ Continue with clopidrogel or tucagelor for 12 months
❑ Discontinue with GP inhibitors

❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Continue Aspirin

❑ Continue with clopidrogel or tucagelor for 12 months
❑ Discontinue with GP inhibitors

❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

References


Template:WikiDoc Sources